Follow The Filings

BEAT Heartbeam

Heartbeam earnings company data as of 4:48 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS -0.09 -0.10 Miss
Rev — — —

Insider trades

Open-market buys and sales by BEAT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BEAT insider trades
  • $901K bought by 8 insiders
  • $1.1M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Richard Ferrari Director
    Buy
    $46K 57,500 shares at $0.8000 +25% to stake
    Traded Apr 16 Filed Apr 24
  2. Tim Cruickshank CFO
    Buy
    $25K 31,250 shares at $0.8000 +76% to stake
    Traded Apr 16 Filed Apr 16
  3. Willem Elfrink Director
    Buy
    $150K 187,500 shares at $0.8000 +53% to stake
    Traded Apr 16 Filed Apr 16
  4. Robert Paul Eno President
    Buy
    $10K 12,500 shares at $0.8000 +52% to stake
    Traded Apr 16 Filed Apr 16
  5. Marga Ortigas-Wedekind Director
    Buy
    $20K 25,000 shares at $0.8000 +22% to stake
    Traded Apr 16 Filed Apr 16
  6. Mark E Strome Director
    Buy
    $600K 750,000 shares at $0.8000 +26% to stake
    Traded Apr 16 Filed Apr 16
  7. Mark E Strome 10% owner
    Sale
    $895K 250,000 shares at $3.58 7.9% of stake
    Traded Dec 17, 2025 Filed Dec 22, 2025
  8. George De Urioste Director
    Sale
    $182K 57,146 shares at $3.19 100% of stake
    Traded Dec 17–18 Filed Dec 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 7 stock grants.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,9.01
SCHEDULE 13D/A —
10-Q
8-K/A 5.02,9.01
8-K 5.07
8-K 3.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 5.02,8.01,9.01
8-K 5.02,9.01
DEF 14A
10-Q
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,8.01,9.01
424B5 PROSPECTUS SUPPLEMENT

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.